DE2810056C2 - - Google Patents

Info

Publication number
DE2810056C2
DE2810056C2 DE2810056A DE2810056A DE2810056C2 DE 2810056 C2 DE2810056 C2 DE 2810056C2 DE 2810056 A DE2810056 A DE 2810056A DE 2810056 A DE2810056 A DE 2810056A DE 2810056 C2 DE2810056 C2 DE 2810056C2
Authority
DE
Germany
Prior art keywords
tablet
use according
tablets
test reagent
freeze
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2810056A
Other languages
German (de)
English (en)
Other versions
DE2810056A1 (de
Inventor
Charles Bernard Taskis
John Worthing Sussex Gb Greenway
Pamela Ann Lower Beeding Sussex Gb Hunter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BEECHAM GROUP Ltd BRENTFORD MIDDLESEX GB
Original Assignee
BEECHAM GROUP Ltd BRENTFORD MIDDLESEX GB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BEECHAM GROUP Ltd BRENTFORD MIDDLESEX GB filed Critical BEECHAM GROUP Ltd BRENTFORD MIDDLESEX GB
Publication of DE2810056A1 publication Critical patent/DE2810056A1/de
Application granted granted Critical
Publication of DE2810056C2 publication Critical patent/DE2810056C2/de
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19782810056 1977-03-16 1978-03-08 Testreagenzien enthaltende tablette, verfahren zu ihrer herstellung und ihre verwendung Granted DE2810056A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB11060/77A GB1594001A (en) 1977-03-16 1977-03-16 Pellets suitable for use in the testing of microorganisms

Publications (2)

Publication Number Publication Date
DE2810056A1 DE2810056A1 (de) 1978-09-28
DE2810056C2 true DE2810056C2 (xx) 1987-09-03

Family

ID=9979270

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19782810056 Granted DE2810056A1 (de) 1977-03-16 1978-03-08 Testreagenzien enthaltende tablette, verfahren zu ihrer herstellung und ihre verwendung

Country Status (14)

Country Link
JP (1) JPS5435279A (xx)
AU (1) AU523959B2 (xx)
BE (1) BE864841A (xx)
CA (1) CA1126138A (xx)
CH (1) CH636643A5 (xx)
DE (1) DE2810056A1 (xx)
DK (1) DK152296C (xx)
FR (1) FR2384022A1 (xx)
GB (1) GB1594001A (xx)
IE (1) IE46580B1 (xx)
NL (1) NL7802799A (xx)
NZ (1) NZ186646A (xx)
SE (1) SE7802928L (xx)
ZA (1) ZA781368B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2964817D1 (en) * 1978-09-06 1983-03-24 Beecham Group Plc Pharmaceutical compositions containing two beta-lactam derivatives
DE2965732D1 (en) * 1978-12-08 1983-07-28 Beecham Group Plc Pharmaceutical composition comprising a water soluble salt of amoxycillin and polyvinylpyrrolidone, and a vial containing a unit dose of said composition
WO1992011386A1 (fr) * 1990-12-21 1992-07-09 Showa Yakuhin Kako Co., Ltd. Agent de detection de cephalosporinase
ES2102505T3 (es) * 1991-05-06 1997-08-01 Dade Microscan Inc Prueba rapida de deteccion de beta-lactamasas inducibles.
US5350679A (en) * 1993-06-14 1994-09-27 Dow Corning Corporation Repeat insult microbial test method

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3138544A (en) * 1961-05-03 1964-06-23 British Drug Houses Canada Ltd Microbial sensitivity testing device
GB1057000A (en) * 1964-12-10 1967-02-01 Deputy Minister Of The Ministe Method of making tablets for testing the sensitivity of bacteria to an antibiotic
GB1275706A (en) * 1970-07-07 1972-05-24 Inst Pentru Controlul De Stat Microtablets for determining the sensitivity of microorganisms to antibiotics and chemotherapeutics
US3928566A (en) * 1970-08-14 1975-12-23 Du Pont Lyophilized biological products
US3932943A (en) * 1970-08-14 1976-01-20 E. I. Du Pont De Nemours And Company Method of preparation of lyophilized biological products
IE41109B1 (en) * 1974-04-20 1979-10-24 Beecham Group Ltd Novel -lactam antibiotic from streptomyces clavuligerus
AU1087176A (en) * 1975-03-03 1977-08-11 Miles Lab Water soluble microbial composition
US4153512A (en) * 1976-04-07 1979-05-08 Fisher Scientific Company Storage stable antibiotic susceptibility test kit and method of testing

Also Published As

Publication number Publication date
ZA781368B (en) 1979-02-28
NL7802799A (nl) 1978-09-19
NZ186646A (en) 1981-03-16
DK152296C (da) 1988-07-11
DK117678A (da) 1978-09-17
BE864841A (fr) 1978-09-13
IE780529L (en) 1978-09-16
FR2384022B1 (xx) 1980-08-29
JPS5435279A (en) 1979-03-15
AU523959B2 (en) 1982-08-26
SE7802928L (sv) 1978-09-17
IE46580B1 (en) 1983-07-27
DK152296B (da) 1988-02-15
CA1126138A (en) 1982-06-22
AU3421578A (en) 1979-09-20
FR2384022A1 (fr) 1978-10-13
GB1594001A (en) 1981-07-30
CH636643A5 (en) 1983-06-15
DE2810056A1 (de) 1978-09-28

Similar Documents

Publication Publication Date Title
DE2950977C2 (xx)
DE2552638A1 (de) Antibiotica
DE3420283A1 (de) Nifedipin-trockenpraeparate und verfahren zu ihrer herstellung
CH645919A5 (de) Verfahren zur herstellung von lagerstabilen praeparationen von mikroorganismen und deren verwendung zum abbau industrieller syntheseprodukte.
DD284599A5 (de) Verfahren zum herstellen einer pharmazeutischen tablette oder eines solchen bolus
DD144277A5 (de) Vorrichtung fuer mikrobiologische arbeiten
AT500063A1 (de) Beschichtete tablettenkerne
Giesbrecht et al. Über Veränderungen der Feinstrukturen von Bakterien unter der Einwirkung von Chloramphenicol
CH665124A5 (de) Verfahren zur herstellung von tabletten mit regulierter wirkstoffabgabe.
DE2741755C2 (de) Überzugsmassen auf Polymerbasis für biologisch aktive Präparate, Verfahren zu ihrer Herstellung sowie mit diesen Überzugsmassen überzogene biologisch aktive Präparate und Verfahren zur Herstellung derselben
DE2810056C2 (xx)
DE2716836C2 (de) Als Musettamycin und Marcellomycin bezeichnete Anthracyclinglycoside, ein Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2200778B2 (de) Verwendung von hochmolekularem, unlöslichem, quervernetztem Polyvinylpyrrolidon als Sprengmittel in festen Arzneiformen
DE2721785C2 (xx)
EP0655249B1 (de) Moenomycin als Arzneimittel zur Behandlung von Magengeschwüren
DE2732335C2 (de) Tablette zur enteralen Verabreichung von Indolyloxyalkanolamin-Derivaten
CH628680A5 (de) Verfahren zur herstellung des neuen antibioticums thienamycin.
DE2115116A1 (de) Verbesserte Gleitmittel und Ver fahren zur Herstellung derselben
EP0885969B1 (de) Nährboden zum Nachweis Streptococcus mutans
DE2106154C3 (de) Verfahren zur Herstellung eines Milchsäurebakterien-Präparates
DE2513416A1 (de) Antibiotica vom beta-lactamtyp enthaltendes stabiles suszeptibilitaetstestmaterial
DE60133775T2 (de) Festes kulturmedium und herstellungsverfahren dafür
DE60115687T2 (de) Stabilisierte arzneizusammensetzungen von oxapenem-3-carbonsäuren durch gefriertrocknen mit pharmazeutischen trägermitteln
CH636523A5 (de) Oral wirksames, antibakterielles mittel.
DE2521922A1 (de) Pharmazeutisches mittel

Legal Events

Date Code Title Description
8126 Change of the secondary classification

Ipc: A61K 9/20

8128 New person/name/address of the agent

Representative=s name: JUNG, E., DIPL.-CHEM. DR.PHIL. SCHIRDEWAHN, J., DI

8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition